ClinicalTrials.gg
RecruitingNCT06464224Updated Jul 23, 2024

Extremes of Respiratory Effort in Weaning Failure From Mechanical Ventilation: a Prospective Observational Study

An observational study in Mechanical Ventilation Pressure High and Weaning Failure, sponsored by Universidade Federal do Rio de Janeiro. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Universidade Federal do Rio de Janeiro · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1
Ages
18 Years and older
Sex
All
01

Study summary

The presence of high levels of respiratory effort in patients under mechanical ventilation may worsen the adjacent lung injury even after adapting protective ventilation. Primary outcome: To evaluate the failure rate of weaning from IMV and its relationship with the lower and upper extremes of respiratory effort and the upper extreme of dynamic pulmonary stress during the first 7 days of spontaneous ventilation. Analyze the influence of these extremes based on the thresholds of Pocc, P0.1 and their derivatives Pmus, Ptp, din and MP: in relation to days off MV (in the 28-day interval); Total weaning time; Rate and time for tracheostomy; Length of stay in the ICU and hospital; In-hospital mortality rate. CAAE: 78185823.4.0000.5249. Prospective multicenter observational study, carried out in the ICUs of Glória D'or and Niteroi D'or hospitals, from January 2024 to July 2026, in patients over 18 years old, undergoing orotracheal intubation and IMV, in their first 7 days on spontaneous ventilation. Hypothesis: Extremes of respiratory effort and dynamic pulmonary stress would be associated with a higher rate of weaning from IMV, as well as longer time on IMV and subsequent longer hospital stay.

Read the detailed description

Introduction: The presence of high levels of respiratory effort in patients under mechanical ventilation may worsen the adjacent lung injury even after adapting protective ventilation, potentially prolonging the MV period. Primary outcome: To evaluate the failure rate of weaning from IMV and its relationship with the lower and upper extremes of respiratory effort and the upper extreme of dynamic lung stress during the first 7 days of spontaneous ventilation. Secondary outcomes: Analyze the influence of these extremes based on the thresholds of Pocc, P0.1 and their derivatives Pmus, Ptp, din and MP: in relation to days off MV (in the 28-day interval); Total weaning time; Rate and time for tracheostomy; Length of stay in the ICU and hospital; evaluate the variation in ventilation distribution through electrical impedance tomography with the extremes of Pocc and Pmus; analyze the fraction of diaphragmatic thickening and diaphragmatic excursion through diaphragmatic ultrasound at the upper and lower levels of Pocc and Pmus; In-hospital mortality rate. Methodology: CAAE: 78185823.4.0000.5249; Prospective multicenter observational study, carried out in the ICUs of Glória D'or and Niteroi D'or Hospitals, from January 2024 to July 2026, in patients over 18 years old, undergoing orotracheal intubation and IMV, in their first 7 days on spontaneous ventilation, excluding if patients with neuromuscular disease; Phrenic nerve injury; MV for less than 24 hours; Previously tracheostomized patient; Age under 18; Use of neuromuscular blocker > 72h; COPD sufferer; Pregnancy; Patient under palliative care; COVID-19 pneumonia; Patients reintubated after extubation in this hospitalization for less than 3 weeks. Statistical analysis: the sample calculation showed an estimated value of 50 patients for two candidate predictor variables; variables will be reported as mean (SD), median (IQ 25 - 75%) or absolute and relative frequencies. The estimate of any association between variables of upper and lower extremes of effort and dynamic pulmonary stress, as well as the ventilatory parameters used will be evaluated with preliminary univariate analysis (chi-square test with Yates' correction or Fisher's exact test), followed by a model multivariate logistic regression analysis adjusted for all clinical variables at hospital admission. Survival time, as well as hospital admission time until the event, will be analyzed using Kaplan-Meier estimates; the log-rank test will be used to compare groups. Values of p \< 0.05 will be considered statistically significant. Hypothesis: Extremes of respiratory effort and dynamic pulmonary stress would be associated with a higher rate of weaning from IMV, as well as longer time on IMV and subsequent longer hospital stay.

02

Conditions studied

  • Mechanical Ventilation Pressure High
  • Weaning Failure

Keywords

  • respiratory drive
  • respiratory effort
03

In context

Lead sponsor

Universidade Federal do Rio de Janeiro is the lead sponsor of 123 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients under mechanical ventilation in their first seven days in spontaneous ventilation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years old, admitted to the Glória D'or hospital, undergoing orotracheal intubation and invasive mechanical ventilation, in their first 7 years on spontaneous ventilation, who accept to participate in the study by signing the free and form (or by their legal responsible).

Exclusion criteria

Exclusion Criteria:

    • Neuromuscular disease;

      • Phrenic nerve injury;
      • MV for less than 24 hours;
      • Previously tracheostomized patient;
      • Age under 18;
      • Use of neuromuscular blocker > 72h;
      • ;
      • Patients with pulmonary fibrosis;
      • Pregnancy;
      • Patient under palliative care;
      • COVID-19 pneumonia;
      • Patients reintubated after extubation in this hospitalization for less than 3 weeks.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1 participant (estimated)
Patient registry
No

Groups and cohorts

  • low respiratory effort

    patients under low respiratory effort

    Behavioral: low respiratory effort

  • high respiratory effort

    patients under high respiratory effort

    Behavioral: high respiratory effort

Interventions

  • Behaviorallow respiratory effort

    patients under respiratory effort lower than -1,5 cmH2O (P0,1) and/or -7 cmH2O (Pocc)

  • Behavioralhigh respiratory effort

    patients under respiratory effort higher than -3,5 cmH2O (P0,1) and/or -15 cmH2O (Pocc)

06

What researchers measure

Primary outcomes

  1. weaning rate from mechanical ventilation

    weaning rate from mechanical ventilation (%)

    Time frame: 2 years

Secondary outcomes

  1. days outside the MV (in the 28-day interval)

    days outside the MV (in the 28-day interval)

    Time frame: 2 years

  2. Total weaning time (first attempt until success)

    Total weaning time (first attempt until success) (days)

    Time frame: 2 years

  3. Rate and time for tracheostomy

    Rate and time for tracheostomy (%)

    Time frame: 2 years

  4. Length of stay in the ICU and hospital

    Length of stay in the ICU and hospital (days)

    Time frame: 2 years

  5. In-hospital mortality rate

    In-hospital mortality rate (%)

    Time frame: 2 years

  6. electrical impedance tomography

    spontaneous breathing trial failure rate (%) evaluated by electrical impedance tomography

    Time frame: 2 years

  7. diaphragmatic ultrassound

    spontaneous breathing trial failure rate (%) evaluated by diaphragmatic ultrassound

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Jan 2025, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2024
First posted
Jun 18, 2024
StartActual
Apr 1, 2024
Primary completionEst.
Jan 2025
CompletionEst.
Jul 2026
Last update
Jul 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06464224
Responsible party
JOSE ROBERTO LAPA E SILVA (Universidade Federal do Rio de Janeiro, Universidade Federal do Rio de Janeiro) — Principal investigator
First posted
Jun 18, 2024
Start date
Apr 1, 2024
Primary completion
Jan 2025 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jul 23, 2024

Study contacts

Amanda Pereira da cruz
Contact
amanda_pereiradacruz@yahoo.com.br
21971739472
Pedro Leme Silva
Contact
pedroleme@biof.ufrj.br
2183430442
Bruno Vilaça
study chair · manager of Physical Therapy team
Bruno Guimarães
study chair · manager of physical therapy team

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion